GlassScriptPhysician profile
Hoi Yuen
NPI 1104260439
$8,994.21
in general payments reported to CMS, 2019-2025
21 companies · $617 in 2025
The $617 reported for 2025 was more than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $222 · 2021: $5,489 · 2022: $1,165 · 2023: $1,169 · 2024: $332 · 2025: $617.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,049 · Food and Beverage: $1,000 · Gift: $69.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,048.58 |
| Food and Beverage | $999.81 |
| Gift | $69.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,034.98 | 2021 | |
| Axonics, INC. | $1,486.45 | 2021-2024 | Axonics |
| Medtronic, INC. | $1,341.17 | 2021-2025 | Interstim, Altaviva |
| Boston Scientific Corporation | $362.55 | 2021-2025 | Upsylon, Advantage System, Lynx System |
| Caldera Medical, INC | $343.01 | 2022-2023 | Desara |
| Astellas Pharma US INC | $300.86 | 2021-2024 | Veozah |
| Coloplast Corp | $228.93 | 2021-2025 | |
| Medtronic USA, INC. | $221.74 | 2019 | |
| Sumitomo Pharma America, INC. | $185.47 | 2023-2024 | Myfembree, Gemtesa |
| Urovant Sciences INC | $136.46 | 2022 | |
| Abbvie INC. | $99.32 | 2022-2025 | |
| Myovant Sciences INC. | $46.98 | 2022 | |
| Allergan, INC. | $34.66 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.72 | 2023 | |
| Femselect INC. | $25.00 | 2024 | Enplace |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $23.02 | 2023 | Vistaseal |
| Convatec INC. | $20.37 | 2024 | |
| Hologic Sales and Service, LLC | $19.81 | 2023 | Omni Hysteroscope, Acessa Provu System |
| Pfizer INC. | $18.59 | 2022 | |
| Scynexis, INC. | $16.63 | 2022 | |
| Olympus America INC. | $16.49 | 2025 | Cysto-Nephro Videoscope, Olympus, Hd Camera Head |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hoi Yuen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.